[{"NetIncomeLoss_1_Q3_USD":-31301000.0,"MarketableSecuritiesCurrent_0_Q3_USD":28719000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":4.31,"GeneralAndAdministrativeExpense_3_Q3_USD":21288000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":9749000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":51098.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":56339.0,"InterestAndOtherIncome_3_Q3_USD":539000.0,"InterestAndOtherIncome_1_Q3_USD":105000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":9299000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":20000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":38231000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":103270000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":5.23,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":3871000.0,"AssetsCurrent_0_Q3_USD":151331000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":861000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":287000.0,"AvailableForSaleSecurities_0_Q3_USD":28719000.0,"CurrentStateAndLocalTaxExpenseBenefit_3_Q3_USD":500000.0,"CommonStockSharesIssued_0_Q3_shares":56487891.0,"Assets_0_Q3_USD":151803000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":20000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":16976000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q3_USD":28699000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-78000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":20000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":45779000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":21657000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":9.0,"AccruedBonusesCurrent_0_Q3_USD":1235000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":7234000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.74,"IncomeTaxExpenseBenefit_3_Q3_USD":-523000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":null,"CommonStockValue_0_Q3_USD":6000.0,"ProceedsFromIssuanceOrSaleOfEquity_3_Q3_USD":103270000.0,"AvailableForSaleSecuritiesAndHeldToMaturitySecurities_0_Q3_USD":28700000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAociForInvestmentTransferredFromAvailableForSaleToEquityMethodAfterTax_3_Q3_USD":null,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAociForInvestmentTransferredFromAvailableForSaleToEquityMethodAfterTax_1_Q3_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":124000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":7000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":114000000.0,"StockIssuedDuringPeriodValueOther_3_Q3_USD":9869000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":6600000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":42000000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-65985000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-31379000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":5330000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0059,"OtherAssetsNoncurrent_0_Q3_USD":120000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":118439000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-78000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":120000.0,"ShareBasedCompensation_3_Q3_USD":5228000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2776000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-145066000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":79274000.0,"CommonStockSharesOutstanding_0_Q3_shares":56487891.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":24672000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_3_Q3_USD":-72000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-66528000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-31301000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":5228000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2715000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-51702000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":9452000.0,"LiabilitiesCurrent_0_Q3_USD":16404000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":4173000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":861000.0,"ProceedsFromStockOptionsExercised_1_Q3_USD":287000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":98000.0,"AdditionalPaidInCapital_0_Q3_USD":280439000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":118439000.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":23816000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":352000.0,"NetIncomeLoss_3_Q3_USD":-66005000.0,"AccountsPayableCurrent_0_Q3_USD":7105000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-109000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":352000.0,"StockholdersEquity_0_Q3_USD":135399000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_3_Q3_USD":20000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1_Q3_USD":-78000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":3550000.0,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"OperatingIncomeLoss_3_Q3_USD":-67067000.0,"OperatingIncomeLoss_1_Q3_USD":-31406000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":1480000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q3_USD":526000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":27000.0,"StockIssuedDuringPeriodSharesOther_1_Q3_shares":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":12.74,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":4.57,"LiabilitiesAndStockholdersEquity_0_Q3_USD":151803000.0,"PreferredStockSharesAuthorized_0_Q3_shares":25000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_3_Q3_shares":316754.0,"SharePrice_0_Q3_USD":12.74,"OperatingExpenses_3_Q3_USD":67067000.0,"OperatingExpenses_1_Q3_USD":31406000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.29,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.56,"ProfitLoss_3_Q3_USD":-66005000.0,"ProfitLoss_1_Q3_USD":-31301000.0,"ShareBasedCompensation_1_Q3_USD":2715000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":637000.0,"Ticker":"PRVB","CIK":"1695357","name":"PROVENTION BIO, INC.","OfficialName":"Provention Bio Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"371519921.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]